Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis.
J Bone Miner Res 21(11):1785-90 (2006) PMID 17002571
Increases in lumbar spine BMD account for 30-41% of the vertebral fracture risk reduction with teriparatide treatment. The remaining fracture risk reduction is caused by improvements in non-BMD determinants of bone strength.
DOI: 10.1359/jbmr.060802
Version: za2963e q8za0 q8zbb q8zce q8zd4 q8ze0 q8zf7 q8zg6